Tower Research Capital (TRC)’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-303
| Closed | -$11K | – | 5453 |
|
|
2025
Q1 | $11K | Sell |
303
-393
| -56% | -$14.3K | ﹤0.01% | 3580 |
|
|
2024
Q4 | $15.3K | Buy |
+696
| New | +$15.3K | ﹤0.01% | 3412 |
|
|
2024
Q3 | – | Sell |
-1,584
| Closed | -$5.78K | – | 5887 |
|
|
2024
Q2 | $5.78K | Buy |
1,584
+13
| +0.8% | +$47 | ﹤0.01% | 4654 |
|
|
2024
Q1 | $5.35K | Buy |
1,571
+847
| +117% | +$2.88K | ﹤0.01% | 4552 |
|
|
2023
Q4 | $1.23K | Sell |
724
-21
| -3% | -$36 | ﹤0.01% | 5413 |
|
|
2023
Q3 | $2.31K | Sell |
745
-2
| -0.3% | -$6 | ﹤0.01% | 5172 |
|
|
2023
Q2 | $3.19K | Buy |
747
+604
| +422% | +$2.58K | ﹤0.01% | 5075 |
|
|
2023
Q1 | $1K | Sell |
143
-423
| -75% | -$2.96K | ﹤0.01% | 5576 |
|
|
2022
Q4 | $7K | Sell |
566
-60
| -10% | -$742 | ﹤0.01% | 4588 |
|
|
2022
Q3 | $5K | Buy |
626
+152
| +32% | +$1.21K | ﹤0.01% | 5154 |
|
|
2022
Q2 | $5K | Sell |
474
-238
| -33% | -$2.51K | ﹤0.01% | 5076 |
|
|
2022
Q1 | $9K | Buy |
712
+232
| +48% | +$2.93K | ﹤0.01% | 4469 |
|
|
2021
Q4 | $8K | Buy |
+480
| New | +$8K | ﹤0.01% | 4804 |
|
|
2021
Q2 | – | Sell |
-442
| Closed | -$14K | – | 5697 |
|
|
2021
Q1 | $14K | Buy |
442
+161
| +57% | +$5.1K | ﹤0.01% | 4154 |
|
|
2020
Q4 | $9K | Sell |
281
-659
| -70% | -$21.1K | ﹤0.01% | 4389 |
|
|
2020
Q3 | $25K | Buy |
+940
| New | +$25K | ﹤0.01% | 3791 |
|
|
2020
Q2 | – | Sell |
-14
| Closed | – | – | 4887 |
|
|
2020
Q1 | $0 | Buy |
+14
| New | – | ﹤0.01% | 3564 |
|